Systematic reviews in health care: Systematic reviews of evaluations of prognostic variables, BMJ, vol.323, issue.7306, pp.224-228, 2001. ,
DOI : 10.1136/bmj.323.7306.224
Cancer: An inflammatory link, Nature, vol.2, issue.7007, pp.405-406, 2004. ,
DOI : 10.1016/S1470-2045(03)01196-3
Inflammation and cancer: back to Virchow? The Lancet 357, pp.539-545, 2001. ,
Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus, The Journal of Experimental Medicine, vol.32, issue.8, pp.1131-1139, 2005. ,
DOI : 10.4049/jimmunol.171.6.3296
Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses, Trends in Immunology, vol.23, issue.11, pp.509-512, 2002. ,
DOI : 10.1016/S1471-4906(02)02317-7
Biomarkers and surrogate end points???the challenge of statistical validation, Nature Reviews Clinical Oncology, vol.3, issue.6, pp.309-317, 2010. ,
DOI : 10.1038/nrclinonc.2010.43
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC, Lung Cancer, vol.71, issue.1, pp.3-10, 2011. ,
DOI : 10.1016/j.lungcan.2010.08.022
Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002. ,
DOI : 10.1006/cyto.1996.0074
Long-Term Survival for Patients With Non???Small-Cell Lung Cancer With Intratumoral Lymphoid Structures, Journal of Clinical Oncology, vol.26, issue.27, pp.4410-4417, 2008. ,
DOI : 10.1200/JCO.2007.15.0284
Evaluating the Impact of Bevacizumab Maintenance Therapy on Overall Survival in Advanced Non???Small-Cell Lung Cancer, Clinical Lung Cancer, vol.14, issue.2 ,
DOI : 10.1016/j.cllc.2012.06.002
Experimental mouse tumour models: what can be learnt about human cancer immunology? Nat Rev Immunol advance online publication, 2011. ,
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells, Journal of Clinical Investigation, vol.122, issue.2, 2012. ,
DOI : 10.1172/JCI61034DS1
Human lung cancer cells express functionally active Toll-like receptor 9, Respiratory Research, vol.60, issue.24 ,
DOI : 10.1016/S1567-5769(00)00050-3
Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.3, issue.11, pp.991-998, 2002. ,
DOI : 10.1038/ni1102-991
The Three Es of Cancer Immunoediting, Annual Review of Immunology, vol.22, issue.1, 2004. ,
DOI : 10.1146/annurev.immunol.22.012703.104803
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase, Nature Protocols, vol.180, issue.8, pp.1064-1072, 2009. ,
DOI : 10.1038/5007
Expression of tumour-specific antigens underlies cancer immunoediting, Nature, vol.4, issue.7385, pp.405-409, 2012. ,
DOI : 10.1038/nature10803
Silencing of TLR4 Decreases Liver Tumor Burden in a Murine Model of Colorectal Metastasis and Hepatic Steatosis, Annals of Surgical Oncology, vol.43, issue.4, pp.1043-1050, 2009. ,
DOI : 10.1245/s10434-009-0325-8
Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer, Infectious Agents and Cancer, vol.7, issue.1, p.14, 2012. ,
DOI : 10.1186/1750-9378-7-14
ERCC1 protein as a guide for individualized therapy of late-stage advanced nonsmall cell lung cancer, Exp Ther Med, vol.2, pp.811-815, 2011. ,
Oncogenic Activity of Epidermal Growth Factor Receptor Kinase Mutant Alleles Is Enhanced by the T790M Drug Resistance Mutation, Cancer Research, vol.67, issue.15, pp.7319-7326, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-4625
Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis, BMC Cancer, vol.7, issue.Suppl 1, p.665, 2010. ,
DOI : 10.1517/14712598.7.8.1257
Tumor-Associated Neutrophils: New Targets for Cancer Therapy, Cancer Research, vol.71, issue.7, pp.2411-2416, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-2583
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus, Nature, vol.203, issue.7300, pp.937-941, 2010. ,
DOI : 10.1038/nature09102
Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9, The Journal of Experimental Medicine, vol.65, issue.13, pp.2931-2942, 2010. ,
DOI : 10.1046/j.1523-1747.2002.01869.x
Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion, Blood, vol.106, issue.7, pp.2424-2432, 2005. ,
DOI : 10.1182/blood-2005-01-0342
Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
DOI : 10.1016/j.cell.2011.02.013
Docétaxel, 2011. ,
Listeria monocytogenes Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 Signaling, Cancer Research, vol.67, issue.9, pp.4346-4352, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-4067
Plasmacytoid dendritic cells lead the charge against tumors, Journal of Clinical Investigation, vol.122, issue.2, pp.481-484, 2012. ,
DOI : 10.1172/JCI61345
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer, Cell, vol.124, issue.4, pp.823-835, 2006. ,
DOI : 10.1016/j.cell.2006.02.016
TLR-4 Signaling Promotes Tumor Growth and Paclitaxel Chemoresistance in Ovarian Cancer, Cancer Research, vol.66, issue.7, pp.3859-3868, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-3948
Combined treatment with intratumoral injection of dendritic cells and topical application of imiquimod for murine melanoma, Clinical and Experimental Dermatology, vol.171, issue.5, pp.541-549, 2007. ,
DOI : 10.1046/j.1523-1747.2000.00833.x
The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice, Cellular and Molecular Immunology, vol.168, issue.5, pp.381-388, 2010. ,
DOI : 10.1007/s00262-008-0581-7
Randomized phase II trial of a tolllike receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer, J, 2008. ,
Tumour immunity: effector response to tumour and role of the microenvironment, The Lancet, vol.371, issue.9614, pp.771-783, 2008. ,
DOI : 10.1016/S0140-6736(08)60241-X
Roles of BCL-2 and MDR1 expression in the efficacy of paclitaxel-based lung cancer chemoradiation, Anticancer Res, vol.31, pp.1431-1436, 2011. ,
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship, Mayo Clinic Proceedings, vol.83, issue.5, p.584, 2008. ,
DOI : 10.1016/S0025-6196(11)60735-0
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans, Journal of Clinical Investigation, vol.122, issue.11, pp.4118-4129, 2012. ,
DOI : 10.1172/JCI63606DS1
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells, Cancer Research, vol.69, issue.14, pp.5996-6004, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-4619
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits, Nature Reviews Cancer, vol.103, issue.4, pp.265-273, 2009. ,
DOI : 10.1038/nrc2620
Imiquimod Enhances the Systemic Immunity Attained by Local Cryosurgery Destruction of Melanoma Lesions, Journal of Investigative Dermatology, vol.127, issue.7, pp.1673-1680, 2007. ,
DOI : 10.1038/sj.jid.5700777
Incidence and Possible Clinical Significance of K-ras Oncogene Activation in Adenocarcinoma of the Human Lung, Cancer Res, vol.48, pp.5738-5741, 1988. ,
Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer, Seminars in Oncology, vol.28, pp.37-44, 2001. ,
DOI : 10.1016/S0093-7754(01)90058-2
DNA repair and cisplatin resistance in non-small-cell lung cancer, Lung Cancer, vol.38, issue.3, pp.217-227, 2002. ,
DOI : 10.1016/S0169-5002(02)00224-6
TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells, The Journal of Immunology, vol.176, issue.8, pp.4894-4901, 2006. ,
DOI : 10.4049/jimmunol.176.8.4894
2010??: septi??me ??dition de la classification TNM, Annales de Pathologie, vol.30, issue.1, pp.2-6, 2010. ,
DOI : 10.1016/j.annpat.2009.12.001
Chemoresistance in Non-Small Cell Lung Cancer, Current Medicinal Chemistry-Anti-Cancer Agents, vol.5, issue.1, pp.73-88, 2005. ,
DOI : 10.2174/1568011053352604
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma, World Journal of Gastroenterology, vol.17, issue.32, p.3745, 2011. ,
DOI : 10.3748/wjg.v17.i32.3745
Macrophage plasticity and polarization: in vivo veritas, Journal of Clinical Investigation, vol.122, issue.3, pp.787-795, 2012. ,
DOI : 10.1172/JCI59643DS1
Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung, New England Journal of Medicine, vol.323, issue.9, pp.561-565, 1990. ,
DOI : 10.1056/NEJM199008303230902
Long-term activation of TLR3 by Poly(I:C) induces inflammation and impairs lung function in mice, Respiratory Research, vol.2, issue.6, p.43, 2009. ,
DOI : 10.1371/journal.ppat.0020053
URL : https://hal.archives-ouvertes.fr/hal-00432116
Epithelial-Mesenchymal Transitions in Development and Disease, Cell, vol.139, issue.5, pp.871-890, 2009. ,
DOI : 10.1016/j.cell.2009.11.007
Immunotherapies for non-small-cell lung cancer and mesothelioma, The Lancet Oncology, vol.13, issue.7, pp.301-310, 2012. ,
DOI : 10.1016/S1470-2045(12)70126-2
Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review), Oncology Reports, vol.12, pp.955-965, 2004. ,
DOI : 10.3892/or.12.5.955
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion, Journal of Experimental & Clinical Cancer Research, vol.29, issue.1, p.92, 2010. ,
DOI : 10.1093/jnci/dji403
dilacérés et placés dans 500?L de PBS 1X avec 16?L soit XXXUI de DNase et 5?L soit XXXUI de libérase ,